Anti Factor Xa activity, fondaparinux(cp) (Citrated plasma, frozen (cp))

Testcode:	E_AF10FO
Specimens:	1 ml Citrated plasma, frozen (cp)
Preanalytics/Notes:	Please always send a separate specimen for this test. To avoid clotting please mix test tube carefully several times directly after collection of blood. Please centrifuge sample at least for 20 minutes (2000 x g). Plasma / supernatant should be transferred by pipette to a collection tube without any buffer or other substances. Please label as citrated plasma. Freeze and send frozen.
Method:	Chromogenic assay
Dimension:	mg/l
Set-up:	Mon Tue Wed Thu Fri Sat Sun
Duration:	5 days
Indication/Significance:	Monitoring of therapy with fondaparinux
Interpretation:	Fondaparinux therapy more… Fondaparinux therapy should be aimed at the above mentioned target values. close

performance by Bioscientia medical service centers

both sex

Monitoring during prophylactic use and in acute coronary syndrome (e.g. 2.5 mg daily): Mean peak steady state plasma concentration: 0.39 - 0.5 mg/l Monitoring during therapeutic use: Mean peak steady state plasma concentration: 1.2 - 1.26 mg/l Applicable only if blood was drawn 2-4 hours after application. (Source: Garcia et al., ACCP Guidelines Parenteral Anticoagulants, 2012)